GENICON, Inc.
PrivateLast Round
Debt
Jul 20, 2017
Total Funding Raised
$12.6M
Company Overview
GENICON, Inc. is a medical device company that designs, produces, and distributes patented surgical instrumentation focused on the laparoscopic surgery market.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GENICON, Inc. Comparables
Compare GENICON, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ackermann Instrumente GmbH | 88% | |
| Applied Medical | 86% | |
| Purple Surgical | 84% | |
GENICON, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 20, 2017 | ||||
| Debt | Apr 21, 2016 | ||||
| Series B | Apr 20, 2015 |
GENICON, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Advantage Capital | Debt, Series B |
| Coastal Enterprises, Inc. | Debt |
| Rand Capital BDC | Debt, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2016
$2M round led by Rand Capital BDC
GENICON, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GENICON, Inc.'s valuation, stock price, and market status.